Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Return on Equity (2018 - 2025)

Autolus Therapeutics (AUTL) has disclosed Return on Equity for 8 consecutive years, with 0.63% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Return on Equity fell 24.0% year-over-year to 0.63%, compared with a TTM value of 0.63% through Jun 2025, down 24.0%, and an annual FY2024 reading of 0.82%, up 20.0% over the prior year.
  • Return on Equity was 0.63% for Q2 2025 at Autolus Therapeutics, down from 0.6% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.08% in Q4 2021 and bottomed at 1.34% in Q4 2023.
  • Average Return on Equity over 5 years is 0.51%, with a median of 0.49% recorded in 2024.
  • The sharpest move saw Return on Equity tumbled -88bps in 2023, then skyrocketed 85bps in 2024.
  • Year by year, Return on Equity stood at 0.08% in 2021, then tumbled by -489bps to 0.46% in 2022, then tumbled by -189bps to 1.34% in 2023, then soared by 64bps to 0.49% in 2024, then plummeted by -30bps to 0.63% in 2025.
  • Business Quant data shows Return on Equity for AUTL at 0.63% in Q2 2025, 0.6% in Q1 2025, and 0.49% in Q4 2024.